Kawaoka, Tomokazu

Publishing since 2005 (Junior)

Has published 30 publications in 6 years

Number of publications published per year by Kawaoka, Tomokazu. (Source : PubMed)

Distribution of publications types for Kawaoka, Tomokazu. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Katamura Y, Aikata H, Kimura Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Ishikawa M, Hieda M, Kakizawa H, Chayama K. Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases.  J. Gastroenterol. Hepatol.  2010  
•  Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: Results and prognostic factors on long-term follow up.  J. Gastroenterol. Hepatol.  2010  
•  Matsui H, Nagashima A, Kawaoka T, Hiraki S, Fukuda S. [A case of giant breast cancer performed a radical excision after neoadjuvant chemotherapy]  Gan To Kagaku Ryoho  2009;36;12  
•  Hiraki S, Matsui H, Nagashima A, Kawaoka T, Fukuda S. [A case of regional advanced colon cancer accompanied with right femoral nerve paresis]  Gan To Kagaku Ryoho  2009;36;12  
•  Kawaoka T, Matsui H, Nagashima A, Hiraki S, Fukuda S, Kudo A. [A case of pyothorax-associated lymphoma treated by operation following radiation therapy]  Gan To Kagaku Ryoho  2009;36;12  
•  Tsumura T, Takaki S, Aikata H, Kimura Y, Katamura Y, Azakami T, Kawaoka T, Tsuge M, Sanetou H, Waki K, Hiramatsu A, Imamura M, Kawakami Y, Takahashi S, Arihiro K, Chayama K. [Case of double cancer of the liver, cholangiocarcinoma and hepatocellular carcinoma detected in a patient with hepatitis C 13 years after diminution of HCV-RNA by interferon treatment]  Nippon Shokakibyo Gakkai Zasshi  2009;106;5  
•  Mori N, Imamura M, Kawakami Y, Saneto H, Kawaoka T, Takaki S, Aikata H, Takahashi S, Chayama K. Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy.  J. Med. Virol.  2009;81;4  
•  Katamura Y, Aikata H, Kimura Y, Azakami T, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Chayama K. Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5-fluorouracil combined with interferon-alpha in a hemodialysis patient.  Hepatol. Res.  2009;39;4  
•  Mitsui F, Aikata H, Azakami T, Katamura Y, Kimura T, Kawaoka T, Saneto H, Takaki S, Hiraga N, Tsuge M, Waki K, Hiramatsu A, Imamura M, Kawakami Y, Takahashi S, Arihiro K, Chayama K. The first Japanese case of COACH syndrome.  Hepatol. Res.  2009;39;3  
•  Kawaoka T, Kawakami Y, Tsuji K, Ito H, Kitamoto M, Aimitsu S, Kawakami H, Jeong SC, Imamura M, Aikata H, Takahashi S, Chayama K. Dose comparison study of pegylated interferon-alpha-2b plus ribavirin in naïve Japanese patients with hepatitis C virus genotype 2: a randomized clinical trial.  J. Gastroenterol. Hepatol.  2009;24;3  

[ See timeline ] [ See all publications ]